Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors
DOI:
10.1038/leu.2014.180
Publication Date:
2014-06-04T13:39:33Z
AUTHORS (37)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (50)
CITATIONS (101)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....